These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 15294264

  • 1. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
    Zecchin M, Di Lenarda A, Proclemer A, Faganello G, Facchin D, Petz E, Sinagra G.
    Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
    [Abstract] [Full Text] [Related]

  • 2. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
    Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH, Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.
    N Engl J Med; 2004 May 20; 350(21):2151-8. PubMed ID: 15152060
    [Abstract] [Full Text] [Related]

  • 3. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.
    Kardiol Pol; 2012 May 20; 70(12):1264-75. PubMed ID: 23264245
    [Abstract] [Full Text] [Related]

  • 4. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP, Adragão PP, Santos KR, Morgado FB, Cavaco DM, Rossi R, Abecasis M, Neves JP, Bonhosrst D, Gomes JL, Gomes RS.
    Rev Port Cardiol; 2005 Mar 20; 24(3):407-15. PubMed ID: 15929624
    [Abstract] [Full Text] [Related]

  • 5. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN, Chan W, Stub D, Prabhu S, Teo EP, Toogood G, Mariani J, Broughton A, Kistler PM.
    Pacing Clin Electrophysiol; 2010 Jun 01; 33(6):696-704. PubMed ID: 20059719
    [Abstract] [Full Text] [Related]

  • 6. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L.
    Rev Esp Cardiol; 2006 Jun 01; 59(6):537-44. PubMed ID: 16790196
    [Abstract] [Full Text] [Related]

  • 7. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S, Haverkamp W, Borggrefe M, Breithardt G, Bocker D.
    Europace; 2009 Mar 01; 11(3):289-96. PubMed ID: 19095687
    [Abstract] [Full Text] [Related]

  • 8. Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: impact of left ventricular function.
    Schaer BA, Ammann P, Sticherling C, Zellweger MJ, Cron TA, Osswald S.
    Int J Cardiol; 2006 Mar 22; 108(1):26-30. PubMed ID: 16516695
    [Abstract] [Full Text] [Related]

  • 9. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA, Vouliotis AI, Tsiachris D, Salourou M, Archontakis S, Dilaveris P, Gialernios T, Arsenos P, Karystinos G, Sideris S, Kallikazaros I, Stefanadis C.
    Circ Arrhythm Electrophysiol; 2013 Jun 22; 6(3):504-12. PubMed ID: 23588627
    [Abstract] [Full Text] [Related]

  • 10. How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?".
    Zecchin M, Merlo M, Pivetta A, Barbati G, Lutman C, Gregori D, Serdoz LV, Bardari S, Magnani S, Di Lenarda A, Proclemer A, Sinagra G.
    Am J Cardiol; 2012 Mar 01; 109(5):729-35. PubMed ID: 22176998
    [Abstract] [Full Text] [Related]

  • 11. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.
    Kardiol Pol; 2012 Mar 01; 70(11):1099-110. PubMed ID: 23180517
    [Abstract] [Full Text] [Related]

  • 12. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A.
    G Ital Cardiol; 1999 May 01; 29(5):514-23. PubMed ID: 10367218
    [Abstract] [Full Text] [Related]

  • 13. [Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation].
    Takeichi K, Kasanuki H, Ohnishi S, Endoh Y, Hosoda S.
    J Cardiol; 1996 Nov 01; 28(5):277-86. PubMed ID: 8953401
    [Abstract] [Full Text] [Related]

  • 14. Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing.
    Brembilla-Perrot B, Suty-Selton C, Beurrier D, Houriez P, Nippert M, de la Chaise AT, Louis P, Claudon O, Andronache M, Abdelaal A, Sadoul N, Juillière Y.
    J Am Coll Cardiol; 2004 Aug 04; 44(3):594-601. PubMed ID: 15358027
    [Abstract] [Full Text] [Related]

  • 15. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T, Stix G, Kastner J, Schneider B, Wolzt M, Schmidinger H.
    Int J Cardiol; 2006 Mar 08; 107(3):360-8. PubMed ID: 16503259
    [Abstract] [Full Text] [Related]

  • 16. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS.
    Eur Heart J; 2000 Dec 08; 21(24):2071-8. PubMed ID: 11102258
    [Abstract] [Full Text] [Related]

  • 17. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG, Dees H, Dobran I, Hennersdorf M, Perings C, Heydthausen M, Winter J, Strauer BE.
    Z Kardiol; 2000 Dec 08; 89 Suppl 3():194-205. PubMed ID: 10810803
    [Abstract] [Full Text] [Related]

  • 18. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A, Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.
    Circulation; 2006 Feb 14; 113(6):776-82. PubMed ID: 16461817
    [Abstract] [Full Text] [Related]

  • 19. Incidence of left ventricular function improvement after primary prevention ICD implantation for non-ischaemic dilated cardiomyopathy: a multicentre experience.
    Verma A, Wulffhart Z, Lakkireddy D, Khaykin Y, Kaplan A, Sarak B, Biria M, Pillarisetti J, Bhat P, Di Biase L, Constantini O, Quan K, Natale A.
    Heart; 2010 Apr 14; 96(7):510-5. PubMed ID: 19884110
    [Abstract] [Full Text] [Related]

  • 20. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
    Grimm W, Hoffmann J Jü, Müller HH, Maisch B.
    J Am Coll Cardiol; 2002 Mar 06; 39(5):780-7. PubMed ID: 11869841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.